Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001062993-22-001878
Filing Date
2022-02-01
Accepted
2022-01-31 18:04:05
Documents
6
Group Members
ALEKSANDR ALEKSANDROVICH MOROZOVALEKSEI CHERNYSHEVALEKSEI GUDZALEX PETER WOUNLUNDALEXANDER KOCHALEXANDER PARKERALEXEY EVGENEEVICH ILINYKHALEXEY ISAEVANDREW GRUBERBUXTON HELMSLEY HOLDINGS, INC.CARLEEN WALSHCHRIS TICHENORDANILIUK KIRILL VLADIMIROVICHDAVID L

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A formsc13da.htm SC 13D/A 990965
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 113608
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 10339
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 28816
5 GRAPHIC exhibit99-2x001.jpg GRAPHIC 4351
6 GRAPHIC exhibit99-3x001.jpg GRAPHIC 4351
  Complete submission text file 0001062993-22-001878.txt   1159096
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87833 | Film No.: 22575888
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS FLOOR 3 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS FLOOR 3 NEW YORK NY 10036 2125615540
Buxton Helmsley Group, Inc. (Filed by) CIK: 0001844298 (see all company filings)

EIN.: 475045339 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SC 13D/A